Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 30 Apr 2026 | 31 Oct 2025 | 31 Jul 2025 | 30 Apr 2025 | 31 Oct 2024 | 31 Jul 2024 |
|---|---|---|---|---|---|---|
| Revenue | 479M | 416M | 391M | 367M | 322M | 300M |
| Cost of revenue | 118M | 97M | 91M | 83M | 76M | 73M |
| Gross profit | 361M | 319M | 301M | 284M | 246M | 227M |
| Research and development | 98M | 86M | 86M | 83M | 77M | 76M |
| Selling, general and administrative | 53M | 66M | 68M | 68M | 63M | 57M |
| Operating expenses | 354M | 321M | 328M | 317M | 293M | 285M |
| Operating income | 7M | −2M | −27M | −33M | −47M | −58M |
| Pre-tax income | 49M | 9M | −15M | −21M | −37M | −49M |
| Income tax | 4M | 1M | 2M | 2M | 493,000 | 1M |
| Net income | 45M | 8M | −17M | −22M | −38M | −50M |
| Earnings per share | 0.08 | 0.01 | −0.03 | −0.04 | −0.07 | −0.09 |
| Earnings per share, diluted | 0.08 | 0.01 | −0.03 | −0.04 | −0.07 | −0.09 |
| Weighted average shares | 582M | 575M | 572M | 568M | 559M | 554M |
| Weighted average shares, diluted | 588M | 586M | 572M | 568M | 559M | 554M |
| Metric | 30 Apr 2026 | 31 Jan 2026 | 31 Oct 2025 | 31 Jul 2025 | 30 Apr 2025 | 31 Jan 2025 | 31 Oct 2024 | 31 Jul 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 219M | 319M | 275M | 258M | 259M | 228M | 181M | 179M |
| Receivables | 285M | 321M | 257M |
| Metric | 30 Apr 2026 | 31 Oct 2025 | 31 Jul 2025 | 30 Apr 2025 | 31 Oct 2024 | 31 Jul 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | 81M | — | — | 53M | — | — |
| Depreciation and amortisation | 8M | 6M | 5M | 5M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 246M |
| 216M |
| 234M |
| 179M |
| 179M |
| Inventory | 52M | 48M | 55M | 48M | 38M | 39M | 39M | 39M |
| Current assets | 1.48B | 1.51B | 1.26B | 1.19B | 1.13B | 1.21B | 1.04B | 1.04B |
| Property, plant and equipment | 84M | 82M | 78M | 70M | 62M | 58M | 56M | 58M |
| Total assets | 2.61B | 2.54B | 2.31B | 2.21B | 2.07B | 2.02B | 1.86B | 1.83B |
| Current liabilities | 912M | 917M | 806M | 792M | 741M | 761M | 654M | 647M |
| Total liabilities | 1.11B | 1.12B | 1.01B | 992M | 946M | 955M | 865M | 861M |
| Equity | 1.51B | 1.42B | 1.30B | 1.21B | 1.13B | 1.07B | 999M | 965M |
| 7M |
| 5M |
| Share-based compensation | 77M | — | — | 77M | — | — |
| Capital expenditure | 8M | — | — | 7M | — | — |
| Investing cash flow | −149M | — | — | −18M | — | — |
| Financing cash flow | −34M | — | — | −356,000 | — | — |